Endurant Capital Management LP - Q1 2022 holdings

$380 Million is the total value of Endurant Capital Management LP's 63 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 76.1% .

 Value Shares↓ Weighting
 INVACARE CORPnote 5.000%11/1$50,194,000
-1.7%
56,727,0000.0%13.22%
+7.3%
SPY BuySPDR S&P 500 ETF TRput$46,022,000
+58.8%
101,900
+67.3%
12.12%
+73.3%
CNC BuyCENTENE CORP DEL$18,373,000
+214.9%
218,235
+208.2%
4.84%
+243.8%
LH SellLABORATORY CORP AMER HLDGS$16,157,000
-21.3%
61,279
-6.3%
4.26%
-14.2%
AZN SellASTRAZENECA PLCsponsored adr$15,940,000
-15.7%
240,271
-26.0%
4.20%
-8.0%
OFIX BuyORTHOFIX MED INC$14,218,000
+2330.4%
434,803
+2210.7%
3.74%
+2556.0%
BMY NewBRISTOL-MYERS SQUIBB CO$14,218,000194,684
+100.0%
3.74%
HUM SellHUMANA INC$12,672,000
-19.6%
29,120
-14.3%
3.34%
-12.3%
THC SellTENET HEALTHCARE CORP$11,293,000
-5.9%
131,376
-10.6%
2.98%
+2.7%
SYNH BuySYNEOS HEALTH INCcl a$9,976,000
+29.1%
123,232
+63.7%
2.63%
+40.8%
AVTR BuyAVANTOR INC$9,669,000
+114.4%
285,901
+167.2%
2.55%
+134.1%
BIO BuyBIO RAD LABS INCcl a$9,660,000
-12.1%
17,151
+18.0%
2.54%
-4.0%
 INVACARE CORPnote 5.000%11/1$9,522,000
-0.5%
10,097,0000.0%2.51%
+8.6%
HOLX SellHOLOGIC INC$9,497,000
-31.5%
123,624
-31.7%
2.50%
-25.2%
SIBN SellSI-BONE INC$9,342,000
-45.2%
413,370
-46.1%
2.46%
-40.2%
MCK NewMCKESSON CORP$8,929,00029,168
+100.0%
2.35%
CI SellCIGNA CORP NEW$6,881,000
-18.2%
28,717
-21.6%
1.81%
-10.7%
AZYO BuyAZIYO BIOLOGICS INC$6,601,000
-2.6%
1,109,479
+3.1%
1.74%
+6.3%
EW NewEDWARDS LIFESCIENCES CORP$5,246,00044,561
+100.0%
1.38%
ISRG NewINTUITIVE SURGICAL INC$5,199,00017,232
+100.0%
1.37%
EHC NewENCOMPASS HEALTH CORP$4,669,00065,653
+100.0%
1.23%
OCUL BuyOCULAR THERAPEUTIX INC$4,574,000
-8.5%
923,963
+28.8%
1.20%
-0.1%
ADAP BuyADAPTIMMUNE THERAPEUTICS PLCsponds adr$4,451,000
+32.2%
2,160,890
+140.7%
1.17%
+44.5%
SELB BuySELECTA BIOSCIENCES INC$4,246,000
-38.7%
3,451,958
+62.6%
1.12%
-33.0%
XBI SellSPDR SER TRs&p biotech$4,174,000
-23.8%
46,440
-5.0%
1.10%
-16.8%
AXSM BuyAXSOME THERAPEUTICS INC$4,151,000
+97.5%
100,299
+80.3%
1.09%
+115.6%
AHCO BuyADAPTHEALTH CORP$3,980,000
+66.2%
248,314
+153.6%
1.05%
+81.3%
INSM BuyINSMED INC$3,884,000
+59.8%
165,280
+85.3%
1.02%
+74.3%
ALBO BuyALBIREO PHARMA INC$3,604,000
+135.7%
120,834
+84.1%
0.95%
+157.2%
GLPG NewGALAPAGOS NVspon adr$3,250,00052,400
+100.0%
0.86%
IDXX NewIDEXX LABS INC$3,134,0005,729
+100.0%
0.83%
QGEN NewQIAGEN NV$2,727,00055,656
+100.0%
0.72%
PINC NewPREMIER INCcl a$2,692,00075,632
+100.0%
0.71%
STRO BuySUTRO BIOPHARMA INC$2,437,000
+46.5%
296,508
+165.2%
0.64%
+59.7%
MTD NewMETTLER TOLEDO INTERNATIONAL$2,424,0001,765
+100.0%
0.64%
FATE BuyFATE THERAPEUTICS INC$2,316,000
+6.0%
59,732
+60.0%
0.61%
+15.7%
TNDM NewTANDEM DIABETES CARE INC$2,121,00018,236
+100.0%
0.56%
KRTX NewKARUNA THERAPEUTICS INC$1,945,00015,342
+100.0%
0.51%
TXG New10X GENOMICS INC$1,896,00024,923
+100.0%
0.50%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$1,826,000
+118.4%
15,400
+153.7%
0.48%
+138.1%
VRTX NewVERTEX PHARMACEUTICALS INC$1,822,0006,982
+100.0%
0.48%
ALNY NewALNYLAM PHARMACEUTICALS INC$1,695,00010,379
+100.0%
0.45%
AFMD NewAFFIMED N V$1,549,000354,492
+100.0%
0.41%
VRDN BuyVIRIDIAN THERAPEUTICS INC$1,539,000
+15.5%
83,217
+23.4%
0.40%
+25.8%
GBT BuyGLOBAL BLOOD THERAPEUTICS IN$1,498,000
+19.6%
43,250
+1.1%
0.40%
+30.8%
IMUX SellIMMUNIC INC$1,475,000
-16.5%
130,567
-29.2%
0.39%
-8.7%
ARGX NewARGENX SEsponsored adr$1,413,0004,480
+100.0%
0.37%
ICUI SellICU MED INC$1,357,000
-26.4%
6,093
-21.5%
0.36%
-19.8%
RYTM SellRHYTHM PHARMACEUTICALS INC$1,219,000
-38.2%
105,792
-46.4%
0.32%
-32.6%
RCUS NewARCUS BIOSCIENCES INC$1,220,00038,650
+100.0%
0.32%
DVA NewDAVITA INCput$1,131,00010,000
+100.0%
0.30%
XBI BuySPDR SER TRcall$1,132,000
-91.2%
126,000
+10.2%
0.30%
-90.4%
MTEM BuyMOLECULAR TEMPLATES INC$1,084,000
+3.0%
314,238
+17.1%
0.29%
+12.6%
CDNA NewCAREDX INC$1,037,00028,048
+100.0%
0.27%
IOVA BuyIOVANCE BIOTHERAPEUTICS INC$1,011,000
-1.9%
60,720
+12.5%
0.27%
+6.8%
NTRA NewNATERA INC$1,007,00024,747
+100.0%
0.26%
KZR NewKEZAR LIFE SCIENCES INC$988,00059,474
+100.0%
0.26%
CRL SellCHARLES RIV LABS INTL INC$939,000
-86.6%
3,308
-82.2%
0.25%
-85.4%
PRAX SellPRAXIS PRECISION MEDICINES I$811,000
-54.0%
79,452
-11.3%
0.21%
-49.8%
GOSS SellGOSSAMER BIO INC$596,000
-53.6%
68,710
-39.5%
0.16%
-49.4%
SellDARIOHEALTH CORP$431,000
-63.5%
73,779
-18.9%
0.11%
-60.0%
PHAS SellPHASEBIO PHARMACEUTICALS INC$322,000
-65.7%
243,795
-32.3%
0.08%
-62.6%
BDSX NewBIODESIX INC$221,000130,753
+100.0%
0.06%
ATNM ExitACTINIUM PHARMACEUTICALS INC$0-66,666
-100.0%
0.00%
ANGO ExitANGIODYNAMICS INC$0-18,125
-100.0%
-0.12%
SBTX ExitSILVERBACK THERAPEUTICS INC$0-84,295
-100.0%
-0.14%
HGEN ExitHUMANIGEN INC$0-154,613
-100.0%
-0.14%
CYH ExitCOMMUNITY HEALTH SYS INC NEW$0-44,847
-100.0%
-0.14%
OMI ExitOWENS & MINOR INC NEW$0-22,489
-100.0%
-0.24%
TMCI ExitTREACE MED CONCEPTS INC$0-57,175
-100.0%
-0.26%
ARAY ExitACCURAY INC$0-245,764
-100.0%
-0.28%
NRIX ExitNURIX THERAPEUTICS INC$0-43,542
-100.0%
-0.30%
HRTX ExitHERON THERAPEUTICS INC$0-165,404
-100.0%
-0.36%
AUPH ExitAURINIA PHARMACEUTICALS INC$0-66,935
-100.0%
-0.37%
ATRC ExitATRICURE INC$0-24,253
-100.0%
-0.41%
PODD ExitINSULET CORP$0-6,394
-100.0%
-0.41%
GDRX ExitGOODRX HLDGS INC$0-68,599
-100.0%
-0.54%
ZGNX ExitZOGENIX INC$0-160,640
-100.0%
-0.63%
IWM ExitISHARES TRput$0-12,000
-100.0%
-0.64%
KNSA ExitKINIKSA PHARMACEUTICALS LTD$0-244,125
-100.0%
-0.69%
SRPT ExitSAREPTA THERAPEUTICS INC$0-33,191
-100.0%
-0.72%
VCYT ExitVERACYTE INC$0-87,343
-100.0%
-0.87%
HAE ExitHAEMONETICS CORP MASS$0-73,914
-100.0%
-0.95%
RCM ExitR1 RCM INC$0-205,400
-100.0%
-1.26%
OCDX ExitORTHO CLINICAL DIAGNOSTICS H$0-245,484
-100.0%
-1.27%
PKI ExitPERKINELMER INC$0-29,543
-100.0%
-1.43%
JNJ ExitJOHNSON & JOHNSON$0-42,762
-100.0%
-1.77%
BDX ExitBECTON DICKINSON & CO$0-34,452
-100.0%
-2.09%
XRAY ExitDENTSPLY SIRONA INC$0-172,384
-100.0%
-2.32%
ABC ExitAMERISOURCEBERGEN CORP$0-115,003
-100.0%
-3.69%
SNY ExitSANOFIsponsored adr$0-424,490
-100.0%
-5.13%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-04-10
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15
SC 13G/A2023-03-21

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings